The document provides an update on the Dementia Discovery Fund (DDF), highlighting its focus on novel biological approaches to develop drugs for dementia. It includes a scientific deep-dive into prioritized areas such as microglial biology and mitochondrial dynamics, led by experts like Professor Beth Stevens and Professor Daria Mochly-Rosen. The document outlines the global burden of dementia, the DDF's investment strategy, and its collaborations with various organizations and experts.
documents/EFTA00799222.pdf
{}